…
MRNA earnings call for the period ending December 31, 2024.…
MRNAs earnings and revenues surpass estimates in the fourth quarter of 2024. The company reiterates 2025 total revenue guidance.…
The biopharma reported disappointing fourth-quarter results, missing bottom line estimates amid a steep decline in COVID-19 vaccine sales.…
These are the stocks posting the largest moves in premarket trading.…
It marks another quarter of growing pains for the company, which is racing to launch new products and recover from…
Das Biotechnologieunternehmen Moderna hat seine Ergebnisse für das vierte Quartal 2024 veröffentlicht.…
Im abgelaufenen Jahresviertel hat Moderna klare Verluste verzeichnet und je Aktie ein Minus von 2,91 US-Dollar erwirtschaftet. Zum Vorjahreswert von…
Moderna, Palo Alto and Applied Materials fall premarket; GameStop, Airbnb rise…
Moderna Inc (NASDAQ:MRNA, ETR:0QF) stock moved higher after the pharmaceutical firm posted mixed results for the fourth quarter. It reported…
Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to scale down manufacturing…
Dem DAX ist am Donnerstag ein weiteres Rekordhoch gelungen. Die neue Bestmarke liegt nun bei 22.624,57 Punkten. Aus dem Handel…
U.S. stocks steady after weak retail sales; Moderna disappoints…
Charlotte (www.aktiencheck.de) - Moderna-Aktienanalyse von BofA Securities:
Aktuelle Bewertung
Tim Anderson von der Bank of America (BofA) hat das Kursziel für Moderna…
Equity markets performed well in January, as they often do, but as the dust settles on that early-year run, the…
…
Buying stocks at significantly reduced valuations can lead to some incredible returns later on. But that doesnt mean that any…
Moderna (MRNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…
When MRNA reports fourth-quarter earnings, investors will likely focus on pipeline updates.…
Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technologys ability to automate complex…
Amgen, CRISPR, Moderna, Sarepta and Vertex are included in this Analyst Blog.…
Shares of Moderna, BioNTech, Novavax, GSK and Pfizer fell on Tuesday following the vote.…
New York (www.aktiencheck.de) - Rating-Update:
Die Analysten von TD Cowen bewerten die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol:…
…
…
Modern application of Talmudic principles using ETFs focuses on balancing growth and income. Check out the Talmudic investment strategy here.…
New York (www.aktiencheck.de) - Rating-Update:
Die Analysten von Evercore ISI stufen die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol:…
New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Goldman Sachs:
1. Hintergrund der Herabstufung
Goldman Sachs hat die Aktie von Moderna Inc. (ISIN: US60770K1079,…
It can be exciting to buy a stock that has been red hot and to jump on the bandwagon --…
Kulmbach (www.aktiencheck.de) - Moderna-Aktienanalyse von "Der Aktionär":
Lars Friedrich vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…
Analyst Salveen Richter downgraded shares of the biotech company from neutral to buy and significantly lowered her price target.…
Here are Wednesdays biggest calls on Wall Street.…
Goldman Sachs cuts Moderna stock rating, slashes target to $51…
Moderna stock rises following RFK Jrs comments…
Based on its share price, down 75% in the last three years, its easy to write off Moderna (NASDAQ: MRNA)…
If a stock is near its 52-week low, it may be a great time to buy it on the dip,…
Für den mRNA-Spezialisten Moderna (MRNA) war die Corona-Pandemie die große Zeit. Mit dem Abebben der Pandemie brach die Nachfrage ein.…
IRW-PRESS: Moderna Inc.: Moderna erhält den Zuschlag für die Belieferung der Europäischen Union mit seinem COVID-19-mRNA-ImpfstoffDie Vereinbarung bietet den teilnehmenden…
IRW-PRESS: Moderna Inc.: Moderna erhält den Zuschlag für die Belieferung der Europäischen Union mit seinem COVID-19-mRNA-Impfstoff
Die…
Moderna secures tender to supply COVID-19 vaccine in EU, Norway, and North Macedonia…
Moderna is testing a norovirus vaccine in a phase three trial. Results could be available as soon as this year.…
Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA approved.…
Moderna stock jumps on AI healthcare prospects…
These are the stocks posting the largest moves in midday trading.…
As Moderna (NASDAQ: MRNA) looks to shore up its business in the wake of its declining coronavirus vaccine sales, its…
…
Exchange-traded funds (ETFs) are great additions to any portfolio. I use them to gain exposure to market segments where I…
Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index.…
Returning 25% in 2024, the S&P 500 delivered a record-breaking year for stock market investors. A resilient global economy coupled…
Moderna stock surges on bird flu vaccine funding…